IPCA Laboratories share news, announcements and annual reports
NSE: IPCALABBSE: 524494Pharmaceuticals & BiotechnologyMid Cap
IPCA Laboratories Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994 on BSE, Feb 1995 on NSE
Last close ₹1,927.80up ₹1.60 (0.08%)BSE ₹1,927.70
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,926.20.
30 Oct: open ₹1,945.20, high ₹1,964.90, low ₹1,921.40
52-week range of traded prices to 30 Oct 2026
₹1,268.00Low, 31 Oct 2025₹2,038.00High, 18 Sep 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹48,909 Cr229th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 37.34
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.07
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.31%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 17.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,53,52767.6% delivered
IPCA Laboratories shareholder meetings
70 filed, newest first. Page 2 of 2.
Jul 2015
2 Jul · Meeting
Register of Members and Share Transfer Books of the Company shall remain closed from July 24, 2015 to July 30, 2015 for the purpose of Annual General Meeting scheduled to be held on July 30, 2015 and payment of final dividend.
Jul 2014
2 Jul · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from July 22, 2014 to July 31, 2014 (both days inclusive) for the purpose of Annual General Meeting scheduled to be held on July 31, 2014 and payment of final dividend.
Dec 2013
Nov 2013
Oct 2013
24 Oct · Meeting
An Extraordinary General Meeting of the Members of the Company will be held on November 29, 2013, to transact the following business: 1. Re-appointment of Mr. Pranay Godha as the Executive Director of the Company for a further period of 5 (five) years with effect from November 11, 2013; and 2. Increase in the investment limit by Foreign Institutional Investors (FIIs) in the equity share capital of the Company.
Aug 2013
Jun 2013
19 Jun · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from July 23, 2013 to July 30, 2013 (both days inclusive) for the purpose of Annual General Meeting scheduled to be held on July 30, 2013 and for the entitlement of final dividend. Further final dividend if sanctioned will be paid on or before August 20, 2013.
Aug 2012
Jun 2012
27 Jun · Meeting
Annual General Meeting of the Company will be held on July 31, 2012. The Register of Members and Share Transfer Books of the Company will remain closed from July 24, 2012 to July 31, 2012, both days inclusive for the purpose of Annual General Meeting and for the entitlement of final dividend @ Re.1.20 per share (60%) which if sanctioned will be paid on or before August 20, 2012.
Aug 2011
Jun 2011
15 Jun · Meeting
Annual General Meeting of the Company will be held on July 28, 2011. The Register of Members and Share Transfer Books of the Company will remain closed from July 20, 2011 to July 28, 2011, both days inclusive for the purpose of Annual General Meeting and for the entitlement of final dividend @ Re.1.20 per share (60%) which if sanctioned will be paid on or before August 20, 2011.
Aug 2010
2 Aug · Meeting
Members of the Company at the Annual General Meeting held on July 29, 2010 have accorded their approval for the following : (1) Adoption of Balance Sheet of the Company as on March 31, 2010 and Profit & Loss Account for the year ended on that date and reports of the Directors and Auditors thereon; (2) Payment of dividend on the equity shares; (3) Re-appointment of Mr. Premchand Godha, Mr.R.S.Hugar and Mr.Babulal Jain as the Directors of the Company; (4) Re-appointment of Mr.Natvarlal Vepari & Co, Chartered Accountants as the Auditors of the Company to hold office till the conclusion of the next Annual General Meeting; (5) Appointment of Mr. Anand T. Kusre as a Director of the Company.
May 2010
28 May · Meeting
Annual General Meeting of the Company will be held on July 29, 2010. The Register of Members and Share Transfer Books of the Company will remain closed from July 20, 2010 to July 29, 2010, both days inclusive for the purpose of Annual General Meeting and for the entitlement of final dividend @ Re.1 per equity share (50%).
Feb 2010
25 Feb · Meeting
Ipca Laboratories Ltd. has informed the Exchange vide its letter dated February 25, 2010 that "The members of the Company at their Extraordinary General Meeting held today have accorded their approval for the following: (1) Sub-division of each of the existing Equity Share having face value of Rs.10/- each (Rupees Ten only) into 5 (Five) equity shares of Rs.2/- (Rupees Two only) each; (2) Alteration in Clause V of the Memorandum of the Association to read as "The Authorised Share Capital of the Company is Rs.45,00,00,000/- (Rupees Forty Five Crores) divided into 22,50,00,000 (Twenty Two Crores Fifty Lacs) Equity Shares of Rs.2/- (Rupees Two) each".3 Feb · Meeting
Ipca Laboratories Ltd. has submitted to the Exchange a copy of the notice of the Extraordinary General Meeting of the members of the Company scheduled to be held on February 25, 2010. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2009
1 Aug · Meeting
Ipca Laboratories Ltd. has informed the Exchange regarding the outcome of the Annual General Meeting held on July 30, 2009.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2009
1 Jun · Meeting
Ipca Laboratories Ltd. has informed the Exchange that the Annual General Meeting of the Company will be held on July 30, 2009. Further, the Register of Members and Share Transfer Books of the Company will remain closed from July 22, 2009 to July 30, 2009, both days inclusive for the purpose of Annual General Meeting and the entitlement of final dividend @ Rs.4/- per share (40%).
May 2008
30 May · Meeting
Ipca Laboratories Ltd. has informed the Exchange that the Annual General Meeting of the Company will be held on July 25, 2008. The Company has further informed the Exchange that the Register of Members and Share Transfer Books of the Company will remain closed from July 16, 2008 to July 25, 2008, both days inclusive for the purpose of Annual General Meeting and the entitlement of final dividend @ Rs.4.50 per share (45%).
Jul 2007
24 Jul · Meeting
Ipca Laboratories Ltd. has informed the Exchange that the members of the Company at the Annual General Meeting held on July 20, 2007 have accorded their approval for the following: (1) Payment of dividend on the equity shares. (2) Re-appointment of Mr. A.K. Jain, Mr. Premchand Godha and Mr. R.S. Hugar as the Directors of the Company. (3) Re-appointment of Mr. Natvarlal Vepari & Co, /Chartered Accountants as the Auditors of the Company to hold office till date of conclusion of the next AGM. (4) Amendment to Employee Stock Option Scheme (ESOS). (5) Extension of benefits of ESOS to Employees and Directors of Subsidiary Companies. (6) Increase in the remuneration payable to Mr. Pranay Godha as President-APIs & Generics.
Jun 2007
14 Jun · Meeting
Ipca Laboratories Ltd. has informed the Exchange that the Annual General Meeting of the Company will be held on July 20, 2007 to transact the business as set out in the notice convening the said Annual General Meeting which will be mailed to all the shareholders of the Company. The company has further informed the Exchange that the Register of Members and Share Transfer Books of the Company will remain closed from July 12, 2007 to July 20, 2007, both days inclusive for the purpose of AGM and Dividend @ Rs.4.00 per share (40%).